Medical University of Vienna,
Austria
University of Milan, European
Institute of Oncology, Italy
08:00 – 08:10 | Opening: High versus low risk definition in ER+/HER2- early breast cancer | Prof. Michael Gnant |
08:10 – 08:35 | Treatment landscape and future strategies for ER+/HER2- early breast cancer | Prof. Giuseppe Curigliano |
08:35 – 08:45 | Discussion and Q&A | Prof. Michael Gnant |